Prolight Diagnostics
19.98 SEK
+0.40 %
Less than 1K followers
PRLD
Nordic SME
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
+0.40 %
+11.62 %
+2.46 %
-10.00 %
-24.03 %
+41.74 %
-11.63 %
-90.92 %
-49.24 %
Prolight Diagnostics develops point-of-care (POC) systems. These are small mobile instruments with disposable test cards that can perform In-Vitro Diagnostic (IVD) tests from a drop of blood. The POC system can contribute to faster and more accurate diagnoses of acute conditions. The company's launch product will be a highly sensitive measurement of troponin to be able to determine and exclude heart attacks.
Read moreMarket cap
240.65M SEK
Turnover
107.3K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
26/2
2026
Annual report '25
26/5
2026
Interim report Q1'26
26/5
2026
General meeting '26
All
Webcasts
Press releases
3rd party
ShowingAll content types
Biostock publicerar artikel om den viktiga milstolpen mot kommersialisering - ”assay design freeze”
Biostock publishes an article about the key milestone toward commercialisation - assay design freeze
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools